(Journal Article): Incretin mimetics as emerging treatments for type 2 diabetes.
 
Joy SV, Rodgers PT, Scates AC
 
IN: Ann Pharmacother 2005; 39(1):110-118
Impact Factor(s) of Ann Pharmacother: 1.739 (2004), 1.822 (2003), 1.729 (2001)

ABSTRACT: OBJECTIVE: To review the physiology, pharmacology, and clinical efficacy of glucagon-like peptide (GLP-1) and the incretin mimetics exenatide and liraglutide in clinical studies. D... Click HERE for details